U.S. markets closed
S&P Futures
4,120.75+0.50(+0.01%)Dow Futures
33,635.00+4.00(+0.01%)Nasdaq Futures
13,816.00+7.25(+0.05%)
Smith & Nephew plc (SNN)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
38.55+0.05 (+0.13%)
At close: 4:00PM EDT
38.55 +0.01 (0.01%)
After hours: 4:00PM EDT
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 38.50 |
| Open | 38.67 |
| Bid | 38.11 x 900 |
| Ask | 39.76 x 900 |
| Day's Range | 38.48 - 38.70 |
| 52 Week Range | 34.29 - 46.10 |
| Volume | 573,056 |
| Avg. Volume | 420,444 |
| Market Cap | 16.921B |
| Beta (5Y Monthly) | 0.39 |
| PE Ratio (TTM) | 37.65 |
| EPS (TTM) | 1.02 |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.75 (1.95%) |
| Ex-Dividend Date | Apr 05, 2021 |
| 1y Target Est | 49.50 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-25% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
View moreRelated Research
- Simply Wall St.
Are Smith & Nephew plc's (LON:SN.) Mixed Financials Driving The Negative Sentiment?
Smith & Nephew (LON:SN.) has had a rough three months with its share price down 14%. We, however decided to study the...
- Zacks
The Zacks Analyst Blog Highlights: Smith & Nephew, Intuitive Surgical, Stryker Corp, Accuray and Medtronic
The Zacks Analyst Blog Highlights: Smith & Nephew, Intuitive Surgical, Stryker Corp, Accuray and Medtronic
- PR Newswire
Smith+Nephew adds Movendo Technology's patient rehabilitation solution to Real Intelligence digital ecosystem
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announces a marketing collaboration with Movendo Technology (Genoa, Italy) that will add personalised robotic patient rehabilitation capability to Smith+Nephew's Real Intelligence enabling technology solutions, creating a fully digitised patient pathway from the pre-op stage to post-rehab phase. The collaboration has launched in Europe and will expand to other regions in the near future.
© 2021 Verizon Media. All rights reserved.
